Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000809269 | SCV000949415 | pathogenic | Hereditary spastic paraplegia 11 | 2024-09-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile1359Tyrfs*30) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SPG11-related conditions. ClinVar contains an entry for this variant (Variation ID: 653485). For these reasons, this variant has been classified as Pathogenic. |
Ai |
RCV002223247 | SCV002501457 | likely pathogenic | not provided | 2021-06-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000809269 | SCV002763934 | likely pathogenic | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing |